Complete response in patient with liver metastasis of HER2-positive breast cancer following therapy with margetuximab: a case report.

Chang, Haiyan; Hu, Ting; Hu, Jie; Ding, Teng; Wang, Qiong; Cheng, Jing

Chang, Haiyan; Hu, Ting; Hu, Jie; Ding, Teng; Wang, Qiong; Cheng, Jing.

Afiliação

Chang H; Department of Oncology, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan.
Hu T; Department of Oncology, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan.
Hu J; Department of Oncology, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan.
Ding T; Medical Affairs Department, Zai Lab (Shanghai) Co., Ltd, Shanghai, China.
Wang Q; Department of Oncology, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan.
Cheng J; Department of Oncology, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan.

Anticancer Drugs ; 34(7): 883-887, 2023 08 01.

Article em En | MEDLINE | ID: mdl-36730303

Assuntos

Neoplasias da Mama; Neoplasias Hepáticas; Feminino; Humanos; Idoso; Neoplasias da Mama/patologia; Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos; Trastuzumab; Receptor ErbB-2/metabolismo; Neoplasias Hepáticas/tratamento farmacológico; Neoplasias Hepáticas/etiologia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Aged / Female / Humans Idioma: En Revista: Anticancer Drugs Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google